Kristin Sherman
Directeur Général chez Kovina Therapeutics, Inc.
Profil
Kristin T.
Sherman is currently the Chief Executive Officer & Director at Kovina Therapeutics, Inc. She is also a Director at LDI Ltd.
LLC and Community Health Network, Inc. (Indiana).
Previously, she was the Chief Financial Officer at Marcadia Biotech, Inc. She holds an MBA from Dartmouth College and an undergraduate degree from DePauw University.
Postes actifs de Kristin Sherman
| Sociétés | Poste | Début |
|---|---|---|
LDI Ltd. LLC
 LDI Ltd. LLC Miscellaneous Commercial ServicesCommercial Services LDI Ltd. LLC develops and operates middle market companies. The firm also invests in manufacturing, distribution and logistics businesses. The company was founded by Howard J. Lacy Sr. in 1912 and is headquartered in Indianapolis, IN. | Directeur/Membre du Conseil | - |
Community Health Network, Inc. (Indiana)
 Community Health Network, Inc. (Indiana) Miscellaneous Commercial ServicesCommercial Services Community Health Network, Inc. provides healthcare services. The frim offers bariatric and medical weight loss, breast care, cancer care, children's health and diet and nutrition services. The company is headquartered in Indianapolis, IN. | Directeur/Membre du Conseil | - |
Kovina Therapeutics, Inc.
 Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | Directeur Général | 01/04/2021 |
Anciens postes connus de Kristin Sherman
| Sociétés | Poste | Fin |
|---|---|---|
Marcadia Biotech, Inc.
 Marcadia Biotech, Inc. Pharmaceuticals: MajorHealth Technology Marcadia Biotech, Inc. develops therapeutic products for diabetes and obesity. It is a biopharmaceutical company focuses on developing a broad portfolio of drug candidates for treatment of diabetes and obesity. The company was founded in 2005 and is headquartered in Carmel, IN. | Directeur Financier/CFO | - |
Formation de Kristin Sherman
| DePauw University | Undergraduate Degree |
| Dartmouth College | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Marcadia Biotech, Inc.
Marcadia Biotech, Inc. Pharmaceuticals: MajorHealth Technology Marcadia Biotech, Inc. develops therapeutic products for diabetes and obesity. It is a biopharmaceutical company focuses on developing a broad portfolio of drug candidates for treatment of diabetes and obesity. The company was founded in 2005 and is headquartered in Carmel, IN. | Health Technology |
LDI Ltd. LLC
LDI Ltd. LLC Miscellaneous Commercial ServicesCommercial Services LDI Ltd. LLC develops and operates middle market companies. The firm also invests in manufacturing, distribution and logistics businesses. The company was founded by Howard J. Lacy Sr. in 1912 and is headquartered in Indianapolis, IN. | Commercial Services |
Community Health Network, Inc. (Indiana)
Community Health Network, Inc. (Indiana) Miscellaneous Commercial ServicesCommercial Services Community Health Network, Inc. provides healthcare services. The frim offers bariatric and medical weight loss, breast care, cancer care, children's health and diet and nutrition services. The company is headquartered in Indianapolis, IN. | Commercial Services |
Kovina Therapeutics, Inc.
Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | Commercial Services |